Chemoinformaics analysis of Decane
Molecular Weight | 142.286 | nRot | 7 |
Heavy Atom Molecular Weight | 120.11 | nRig | 1 |
Exact Molecular Weight | 142.172 | nRing | 0 |
Solubility: LogS | -0.921 | nHRing | 0 |
Solubility: LogP | 1.053 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 31.3694 |
nHD | 0 | BPOL | 22.0706 |
QED | 0.472 |
Synth | 3.307 |
Natural Product Likeliness | -1.343 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.384 |
MDCK | 0.0000488 |
BBB | 0.997 |
PPB | 0.255245 |
VDSS | 1.007 |
FU | 0.747016 |
CYP1A2-inh | 0.785 |
CYP1A2-sub | 0.779 |
CYP2c19-inh | 0.053 |
CYP2c19-sub | 0.313 |
CYP2c9-inh | 0.028 |
CYP2c9-sub | 0.467 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.153 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.282 |
CL | 9.887 |
T12 | 0.835 |
hERG | 0.011 |
Ames | 0.241 |
ROA | 0.966 |
SkinSen | 0.447 |
Carcinogencity | 0.586 |
EI | 0.991 |
Respiratory | 0.977 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.905783 |